MedAI Verdict

AI Radiology

Editorial illustration: a chest radiograph alongside a magnifying glass highlighting flagged regions in blue.

Hyperfine Swoop vs Qure.ai

All comparisons
47/ 100

Hyperfine Swoop

Solid choice
50/ 100

Qure.ai

Solid choice

Qure.ai reads X-rays and head CTs while Hyperfine builds a brain scanner, so no purchase puts them head to head. Qure.ai sells to hospitals and TB screening programs. Its qER head CT triage was cleared in 2020 (K200921), qXR-LN covers lung nodules on adult frontal chest radiographs, and Qure.ai reports a WHO endorsement from 2021 for TB screening. An independent 12-product evaluation put qXR v3 at 95.5% sensitivity and 48.7% specificity at one threshold. Hyperfine sells to ICUs and resource-limited hospitals. A Malawi case review praises Swoop for bedside brain imaging where a fixed MRI suite is out of reach, and a research paper estimates about $50,000 per system. Qure.ai publishes no price, and Hyperfine's 10-K summary describes ownership plus an annual service agreement.

Radiology · Reviewed November 2, 2026

On this page
Hyperfine Swoop logo

Hyperfine Swoop

by Hyperfine

Portable 0.064T brain MRI (Swoop) with Optive AI image reconstruction. Also BrainInsight AI brain morphometry.

Qure.ai logo

Qure.ai

by Qure.ai

AI for chest X-ray (qXR), head CT (qER) and lung nodule CT, with TB screening. The homepage cites sites across 107 countries.

When to pick each one

Hyperfine Swoop

  • Malawi review praises bedside brain imaging
  • Older research paper estimates about $50,000 per system
Read the full Hyperfine Swoop review

Qure.ai

  • qER head CT triage, 510(k) cleared in 2020
  • Qure.ai reports a WHO endorsement for TB screening, 2021
  • CE Class IIb under MDR for qXR v4.0 and qCT
Read the full Qure.ai review

Score

Each row shows points earned of points available under the published rubric.

Hyperfine Swoop

47of 100Solid choice

Qure.ai

50of 100Solid choice
Score by dimension for Hyperfine Swoop and Qure.ai
DimensionHyperfine SwoopQure.aiDifference
FDA clearance18 / 1818 / 180
HIPAA / SOC2 / BAA0 / 100 / 100
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers12.7 / 18.212.7 / 18.20
RCT / meta-analysis / systematic review0 / 7.80 / 7.80
Funding & adoption signal6 / 128.4 / 12-2.4
Pricing transparency2.5 / 52.5 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Hyperfine Swoop

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Per the FY2025 10-K summary, systems are owned, with an annual software, service and support agreement after a one-year warranty on 36- or 60-month terms. Dollar amounts were not found.

Qure.ai

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Grant funding is not stated on Qure pages.

Evidence

Compliance and integrations

Documented from each vendor’s own pages.

SpecHyperfine SwoopQure.ai
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot statedNot stated
FoundedNot statedNot stated
HQUSIN

Scroll horizontally to see both columns.

Common questions

Open the full radiology comparison

Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.

See all radiology